Dr Adams is the co-founder of a number of successful diagnostic and pharmaceutical companies including Genprobe, Hybritech, Genta and Leucadia Technologies. Dr Adams is a senior executive of Iris which acquired Leucadia Technologies.
Dr Adams said: “Xenomics trans-renal DNA disease detection diagnostic platform offers significant advantages over conventional tests. The company is using this platform to create truly diagnostic applications that are only achievable using Xenomics’s patented trans-renal technology.”